Stay updated on Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.

Latest updates to the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page
- Check6 days agoChange DetectedAn updated revision tag v3.6.3 is now displayed on the page, replacing the previous v3.6.0 tag. This indicates a recent deployment/maintenance update to the site rather than a change to the study data or content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study record now shows that recruitment is closed ('No longer looking for participants'), signaling no new enrollments and impacting potential participants. Additionally, helper/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the Intervention/Treatment header was reformatted.SummaryDifference0.4%

- Check27 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the page's version or content structure.SummaryDifference0.1%

- Check49 days agoChange DetectedA new page revision tag Revision: v3.5.4 was added. Several elements were removed, including clinical study report synopsis, the AbbVie sponsor label, the Helpful Links Provided by section, and the previous Revision: v3.5.3.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site or display software update rather than any study content change.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.